Full Description
The present volume of the Boerhaave series intends to be a reflexion of our present knowledge in the expanding field of early diagnosis and prevention of inherited disorders. Early diagnosis can mean detection of a carrier state in one or both potential parents, detection of a specific inherited disease in a previously born child or during a pregnancy at risk, or during various stages of the life of an already born individual. The first chapters will discuss inherited disorders manifesting later in life. In Huntington's Chorea detection may be possible from the age of 20 or 30 onwards, while in myotonic dystrophy it will be seen that detection may be possible soon after birth. Retinoblastoma serves as example of a disease manifesting in early infancy and which is partially treatable by surgical intervention. The same early onset does occur in phenylketonuria and cystic fibrosis. Both diseases provide examples of the possibilities of population screening, while in phenylketonuria an eminently succesful treatment is found in a restricted diet. For the usually early manifesting sphingolipidoses no treatment exists as yet, but enzyme treatment might in the near future become a reality. Spina bifida and anencephaly are not simple inherited Mendelian dis orders but they are discussed in this volume because prevention is possible by antenatal diagnosis and subsequent interruption of the pregnancy if re quested by the future parents. Further views on antenatal diagnosis notably in inborn errors of metabolism are presented in a following chapter.
Contents
Huntington's chorea.- Dystrophia myotonica.- Retinoblastoma.- An approach to the problem of hereditary and non-hereditary retinoblastoma.- Screening for phenylketonuria.- The early diagnosis and prevention of cystic fibrosis.- Sphingolipidoses.- Spina bifida and anencephaly.- Prenatal diagnosis of genetic disease.- Detection of carriers of hemophilia.- Family detection of genetic diseases.- Genetic counseling: present status and future prospects.- Problems of screening for genetic disease.- Population effects of genetic screening.- Panel discussion: Ethical aspects of prevention.- Index of subjects.
